Luxiq (betamethasone valerate) Foam
Company: Connetics Corporation
Approval Status: Approved June 1999
Treatment for: Dermatology
Areas: Dermatology/Plastic Surgery
General Information
Other Useful Resources
Luxiq (betamethasone valerate) Foam has been approved for the treatment of dermatoses of the scalp.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
Medical Dictionary Searches
